Workshop: New Guideline on Modified Release Products

The new European guideline defining the requirements on the pharmacokinetic and clinical evaluation of modified release dosage forms (EMA/CPMP/EWP/280/96 Corr1)  comes into effect on June 1st, 2015. We would like to draw your attention to a workshop planned and realized by AGAH together with the EUFEPS Network on Bioavailability and Biopharmaceutics Weiterlesen...

Experience meets Expertise – Meet us in Brussels

For the first time we will be present at a conference with an exhibition. Why? And why as a joint appearance together with 3 highly specialised CROs? Weiterlesen...
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on index